Intelliphecy is aiming to innovate technologies in the hope to win the war against cancer, aspiring to out-smart cancer cells with an intelligent prophecy. At the core of our technology portfolio lies artificial intelligence driven big data analytics, which is devoted to predictive modeling of cancer hallmarks using quantitative information. Our research and development is grounded in both identification of cancer at early stage and prediction of optimal treatment strategy for individual cancer patient. Intelliphecy has established research collaborations with major cancer centres throughout China.
